头高位对心肺复苏影响的系统评价与荟萃分析
该系统评价与荟萃分析检索PubMed、EMBASE和Cochrane Library(各库建库至2021年5月),纳入7项动物研究共131只动物,比较头高位心肺复苏(HUP CPR)与常规仰卧位心肺复苏(SUP CPR)。主要结局脑灌注压(CerPP)在HUP组显著升高(MD 10.37;95% CI 7.11-13.64;p<0.01;I2=58%),冠状动脉灌注压(CoPP)显著升高(MD 7.56;95% CI 1.84-13.27;p=0.01;I2=75%),颅内压(ICP)显著降低(MD -13.66;95% CI -18.6至-8.71;p<0.01;I2=96%);平均动脉压(MAP)和自主循环恢复(ROSC)频率无显著差异。与立即反向Trendelenburg位抬头的不良结果相反,在短暂基础CPR并用主动按压-减压(ACD)和阻抗阈值(ITD)装置启动循环后,以平稳渐进方式仅抬高头部和胸部时,研究结局显著改善。
要点
- 在动物实验模型中,与常规仰卧位CPR相比,头高位CPR显著升高脑灌注压(MD 10.37;95% CI 7.11-13.64;p<0.01;I2=58%)和冠状动脉灌注压(MD 7.56;95% CI 1.84-13.27;p=0.01;I2=75%)。
- 头高位CPR显著降低颅内压(MD -13.66;95% CI -18.6至-8.71;p<0.01;I2=96%)。
- 合并所有研究方法后,头高位CPR与仰卧位CPR在平均动脉压(MD -1.63;95% CI -10.77-7.52;p=0.73;I2=93%)和ROSC频率(RR 0.9;95% CI 0.31-2.60;p=0.84;I2=65%)上无显著差异。
- 与立即以反向Trendelenburg位抬头的不良结局相反,在短暂基础CPR并用ACD和ITD装置启动循环后,以平稳渐进方式仅抬高头部和胸部时,研究结局显著改善。
- 在实验模型中,短暂ACD和ITD装置循环启动后逐步抬高头胸部可显著改善CoPP、降低ICP、提高CerPP并维持MAP,该效应立即出现、持续存在并与结局改善相关。
适用人群与场景
- 实验模型(动物研究)中的心脏骤停心肺复苏场景,共纳入7项研究131只动物。
处置流程与药物剂量
- 在短暂基础CPR并用主动按压-减压(ACD)和阻抗阈值(ITD)装置启动循环后,以平稳渐进方式仅抬高头部和胸部实施头高位CPR。
- 避免立即以反向Trendelenburg位抬头,因采用该方式的研究显示结局更差。
研究设计与关键结果
- 系统评价与荟萃分析,纳入7项动物研究共131只动物,比较头高位CPR与常规仰卧位CPR。
- 主要结局脑灌注压:头高位CPR较仰卧位CPR显著升高(MD 10.37;95% CI 7.11-13.64;p<0.01;I2=58%)。
- 冠状动脉灌注压:头高位CPR较仰卧位CPR显著升高(MD 7.56;95% CI 1.84-13.27;p=0.01;I2=75%)。
- 颅内压:头高位CPR较仰卧位CPR显著降低(MD -13.66;95% CI -18.6至-8.71;p<0.01;I2=96%)。
- 合并所有研究方法后,平均动脉压无显著差异(MD -1.63;95% CI -10.77-7.52;p=0.73;I2=93%)。
- 合并所有研究方法后,ROSC频率无显著差异(RR 0.9;95% CI 0.31-2.60;p=0.84;I2=65%)。
- 与立即以反向Trendelenburg位抬头的研究结局更差相反,在短暂基础CPR并用ACD和ITD装置启动循环后,以平稳渐进方式仅抬高头部和胸部时,研究结局显著改善。
证据类型、等级与局限
- 证据类型:系统评价与荟萃分析,纳入7项动物实验研究(共131只动物)。
- 异质性:CerPP分析I2=58%,CoPP分析I2=75%,ICP分析I2=96%,MAP分析I2=93%,ROSC分析I2=65%。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在实验模型中,短暂ACD和ITD装置循环启动后逐步抬高头胸部可显著改善CoPP、降低ICP、提高CerPP并维持MAP,该效应立即出现、持续存在并与结局改善相关。
- 采用立即反向Trendelenburg位抬头的研究显示结局更差,与逐步抬高头胸部的研究结果相反。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Experimental studies of head-up positioning (HUP) during cardiopulmonary resuscitation (CPR) have had some degree of conflicting published results. The current study aim was to analyze and reconcile those discrepancies in order to better clarify the effects of HUP CPR compared to conventional supine (SUP) CPR.
METHODS: Three databases (PubMed, EMBASE and Cochrane Library) were searched comprehensively (from each respective database's inception to May 2021) for articles addressing HUP CPR. The primary outcome to be observed was cerebral perfusion pressure (CerPP), and secondary outcomes were mean intracranial pressure (ICP), mean arterial pressure (MAP), coronary perfusion pressure (CoPP) and frequencies of return of spontaneous circulation (ROSC).
RESULTS: Seven key studies involving 131 animals were included for analysis. Compared to SUP CPR, CerPP (MD 10.37; 95% CI 7.11-13.64; p < 0.01; I2 = 58%) and CoPP (MD 7.56; 95% CI 1.84-13.27, p = 0.01; I2 = 75%) increased significantly with HUP CPR, while ICP (MD - 13.66; 95% CI - 18.6 to -8.71; p < 0.01; I2 = 96%) decreased significantly. Combining all study methodologies, there were no significant differences detected in MAP (MD - 1.63; 95% CI - 10.77-7.52; p = 0.73; I2 = 93%) or frequency of ROSC (RR 0.9; 95% CI 0.31-2.60; p = 0.84; I2 = 65%). However, in contrast to worse outcomes in studies using immediate elevation of the head in a reverse Trendelenburg position, study outcomes were significantly improved when HUP (head and chest only) was introduced in a steady, graduated manner following a brief period of basic CPR augmented by active compression-decompression (ACD) and impedance threshold (ITD) devices.
CONCLUSION: In experimental models, gradually elevating the head and chest following a brief interval of circulatory priming with ACD and ITD devices can enhance CoPP, lower ICP and improve CerPP significantly while maintaining MAP. This effect is immediate, remains sustained and is associated with improved outcomes.
参考来源
- Huang CC, Chen KC, Lin ZY, et al. The effect of the head-up position on cardiopulmonary resuscitation: a systematic review and meta-analysis. Crit Care. 2021. PMID: 34717715. doi:10.1186/s13054-021-03797-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。